Brief: aap Implantate sees FY sales and EBITDA at lower end of guidance
14/11/2017 07:50
Nov 14 (Reuters) - AAP IMPLANTATE AG AAQG.DE :
* EBITDA IMPROVED IN Q3 OF 2017 BY 11% YEAR-ON-YEAR TO EUR -1.6 MILLION (Q3/2016: EUR -1.8
MILLION)
* Q3 SALES OF EUR 2.6 MILLION (Q3/2016: EUR 2.9 MILLION)
* AAP EXPECTS SALES AND EBITDA TO BE AT LOWER END OF GUIDANCE FOR FINANCIAL YEAR 2017
Source text for Eikon: ID:nEQ9nbClza
Further company coverage: AAQG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on aap Implantate AG
See all newsBrief: Aap Confirms Rubino Di Girolamo As CEO Through The End Of 2028 COO Agnieszka Mierzejewska Will Leave The Company At The End Of The Year
Brief: aap Implantate Says Postponement Of Publication Of Annual Financial Statements
Brief: Aap Implantate AG Says Increases Its EBITDA In 9M From - 1.6 Mln Euros To 0 Euros
Brief: aap Implantate Says Resumes Step-By-Step Restart Of It Systems
Brief: Aap Implantate Says Possible Cyber Attack On Co